Electrospray mass spectrometry for quantitative plasma proteome analysis.

Ligand-binding mass spectrometry to study biotransformation of fusion protein drugs and guide immunoassay development: strategic approach and application to peptibodies targeting the thrombopoietin receptor. AAPS J (2010) 1.01

Proteomic consequences of expression and pathological conversion of the prion protein in inducible neuroblastoma N2a cells. Prion (2010) 0.77

Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30

A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem (2003) 29.58

Electrospray ionization for mass spectrometry of large biomolecules. Science (1989) 16.50

Analytical properties of the nanoelectrospray ion source. Anal Chem (1996) 7.12

Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res (2006) 4.32

General framework for developing and evaluating database scoring algorithms using the TANDEM search engine. Bioinformatics (2006) 3.35

Quantitative analysis of acrylamide labeled serum proteins by LC-MS/MS. J Proteome Res (2006) 2.10

Modification of cysteine residues by alkylation. A tool in peptide mapping and protein identification. Anal Chem (1998) 1.90

Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics (2005) 1.59

A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics (2005) 1.08

Computational Proteomics Analysis System (CPAS): an extensible, open-source analytic system for evaluating and publishing proteomic data and high throughput biological experiments. J Proteome Res (2006) 4.32

Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem (2004) 2.26

Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J Proteome Res (2004) 1.19

Intact-protein based sample preparation strategies for proteome analysis in combination with mass spectrometry. Mass Spectrom Rev (2005) 1.17

Harnessing immunity for cancer marker discovery. Nat Biotechnol (2003) 0.99

Brain-specific proteins decline in the cerebrospinal fluid of humans with Huntington disease. Mol Cell Proteomics (2008) 0.96

Autoantibody profiling for cancer detection. Clin Lab Med (2009) 0.92

Proteomic profiling of the tumor microenvironment: recent insights and the search for biomarkers. Genome Med (2014) 0.81

Impact of protein stability, cellular localization, and abundance on proteomic detection of tumor-derived proteins in plasma. PLoS One (2011) 0.80

A systems approach to the proteomic identification of novel cancer biomarkers. Dis Markers (2010) 0.80

BiomarkerDigger: a versatile disease proteome database and analysis platform for the identification of plasma cancer biomarkers. Proteomics (2009) 0.80

Focus on breast cancer proteomics. Proteomics Clin Appl (2009) 0.75

It takes a village to develop biomarkers. J Proteome Res (2007) 0.75

The emerging field of protein microarrays. Proteomics (2003) 0.75